Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$7,770,370
-$118,107 QoQ
Shares Held
21,458
-4.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#641
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Dec 31, 2024CallValue
$1,191,689
CallShares
1,200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. AMGN ranks #5 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
This page
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,770,370 | 21,458 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $7,888,477 | 22,420 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $7,529,111 | 23,003 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $6,473,950 | 22,941 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,329,132 | 22,668 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $6,698,013 | 21,499 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $5,785,165 | 22,196 | Shares | Sole | 2025-02-12 | |
| 2024-12-31 | $1,191,689 | 1,200,000 | Call | Sole | 2025-02-12 | |
| 2024-09-30 | $7,434,029 | 23,072 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,174,164 | 22,961 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $6,018,770 | 21,169 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,097,095 | 21,169 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,689,917 | 21,171 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,641,772 | 20,907 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,123,649 | 21,194 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,414,060 | 20,614 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,628,814 | 20,536 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $4,967,942 | 20,419 | Shares | Sole | 2022-08-26 | |
| 2021-12-31 | $4,227,411 | 18,791 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,835,568 | 18,037 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,346,550 | 17,832 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $6,020,455 | 24,197 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $5,555,327 | 24,162 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,265,298 | 24,651 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,917,537 | 29,329 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,836,393 | 28,789 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||